ADC Therapeutics SA (ADCT) support and resistance · rev $70.8M
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
This page maps ADC Therapeutics SA (ADCT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ADCT revenue for 2024-12-31 was $70.8M. Net income was -$157.8M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. ADCT currently screens at market cap $141.2M.
ADCT currently screens at market cap $141.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ADCT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ADCT quote page for the session range and the stock page for the full model.
Not investment advice.